This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tugwell, B. D.
Right arrow Articles by Cieslak, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tugwell, B. D.
Right arrow Articles by Cieslak, P. R.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Varicella-Zoster Infections
PEDIATRICS Vol. 113 No. 3 March 2004, pp. 455-459

Chickenpox Outbreak in a Highly Vaccinated School Population

Barna D. Tugwell, MD*,{ddagger}, Lore E. Lee, MPH{ddagger}, Hilary Gillette, RN, MPH{ddagger}, Eileen M. Lorber, MD{ddagger}, Katrina Hedberg, MD, MPH{ddagger} and Paul R. Cieslak, MD{ddagger}

* Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia
{ddagger} Oregon Department of Human Services, Portland, Oregon

Objective. We investigated a chickenpox outbreak that started in an Oregon elementary school in October 2001, after public schools began phasing in a varicella vaccination requirement for enrollment. We sought to determine the rate of varicella vaccination and effectiveness and risk factors for breakthrough disease.

Methods. A chickenpox case was defined as an acute maculopapulovesicular rash without other explanation occurring from October 30, 2001 through January 27, 2002 in a student without a prior history of chickenpox. We reviewed varicella vaccination records and history of prior chickenpox, and we calculated vaccine effectiveness. We evaluated the effects of age, gender, age at vaccination, and time since vaccination on risk of breakthrough disease (ie, chickenpox occurring >42 days after vaccination).

Results. Of 422 students, 218 (52%) had no prior chickenpox. Of these, 211 (97%) had been vaccinated before the outbreak. Twenty-one cases occurred in 9 of 16 classrooms. In these 9 classrooms, 18 of 152 (12%) vaccinated students developed chickenpox, compared with 3 of 7 (43%) unvaccinated students. Vaccine effectiveness was 72% (95% confidence interval: 3%–87%). Students vaccinated >5 years before the outbreak were 6.7 times (95% confidence interval: 2.2–22.9) as likely to develop breakthrough disease as those vaccinated ≤5 years before the outbreak (15 of 65 [23%] vs 3 of 87 [3%]).

Conclusions. A chickenpox outbreak occurred in a school in which 97% of students without a prior history of chickenpox were vaccinated. Students vaccinated >5 years before the outbreak were at risk for breakthrough disease. Booster vaccination may deserve additional consideration.

Key Words: chickenpox • chickenpox vaccine • disease outbreaks • risk factors

Abbreviations: MMR, measles, mumps, and rubella • CI, confidence interval

Received for publication May 2, 2003; Accepted Jul 24, 2003.




This article has been cited by other articles:


Home page
 PediatricsHome page
M. C. Lindley, L. Boyer-Chu, D. B. Fishbein, M. Kolasa, A. B. Middleman, T. Wilson, J. Wolicki, S. Wooley, and for the Working Group on the Role of Schools in De
The Role of Schools in Strengthening Delivery of New Adolescent Vaccinations
Pediatrics, January 1, 2008; 121(Supplement_1): S46 - S54.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
Should the UK introduce varicella vaccine?
Arch. Dis. Child., December 1, 2007; 92(12): 1051 - 1052.


Home page
 PediatricsHome page
Committee on Infectious Diseases
Prevention of Varicella: Recommendations for Use of Varicella Vaccines in Children, Including a Recommendation for a Routine 2-Dose Varicella Immunization Schedule
Pediatrics, July 1, 2007; 120(1): 221 - 231.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. S. Chaves, P. Gargiullo, J. X. Zhang, R. Civen, D. Guris, L. Mascola, and J. F. Seward
Loss of Vaccine-Induced Immunity to Varicella over Time
N. Engl. J. Med., March 15, 2007; 356(11): 1121 - 1129.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. M. Davis, M. Marin, A. E. Cowan, D. Guris, and S. J. Clark
Physician Attitudes Regarding Breakthrough Varicella Disease and a Potential Second Dose of Varicella Vaccine
Pediatrics, February 1, 2007; 119(2): 258 - 264.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
Public Health Response to Varicella Outbreaks--United States, 2003-2004
JAMA, December 6, 2006; 296(21): 2547 - 2549.
[Full Text] [PDF]

Home page
 PediatricsHome page
A. S. Lopez, D. Guris, L. Zimmerman, L. Gladden, T. Moore, D. T. Haselow, V. N. Loparev, D. S. Schmid, A. O. Jumaan, and S. L. Snow
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Pediatrics, June 1, 2006; 117(6): e1070 - e1077.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K. S. Reisinger, M. L. Hoffman Brown, J. Xu, B. J. Sullivan, G. S. Marshall, B. Nauert, D. O. Matson, P. E. Silas, Protocol 014 Study Group for ProQuad, F. Schodel, et al.
A Combination Measles, Mumps, Rubella, and Varicella Vaccine (ProQuad) Given to 4- to 6-Year-Old Healthy Children Vaccinated Previously With M-M-RII and Varivax
Pediatrics, February 1, 2006; 117(2): 265 - 272.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. B. Haddad, M. B. Hill, A. T. Pavia, C. E. Green, A. O. Jumaan, A. K. De, and R. T. Rolfs
Vaccine Effectiveness During a Varicella Outbreak Among Schoolchildren: Utah, 2002-2003
Pediatrics, June 1, 2005; 115(6): 1488 - 1493.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. Marin, H. Q. Nguyen, J. Keen, A. O. Jumaan, P. M. Mellen, E. B. Hayes, K. F. Gensheimer, J. Gunderman-King, and J. F. Seward
Importance of Catch-up Vaccination: Experience From a Varicella Outbreak, Maine, 2002-2003
Pediatrics, April 1, 2005; 115(4): 900 - 905.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
S. Hambleton and A. A. Gershon
Preventing Varicella-Zoster Disease
Clin. Microbiol. Rev., January 1, 2005; 18(1): 70 - 80.
[Abstract] [Full Text] [PDF]

Home page
 AAP Grand RoundsHome page
D. W. Schiff
Contagiousness of Varicella in Vaccinated Cases
AAP Grand Rounds, November 1, 2004; 12(5): 61 - 61.
[Full Text] [PDF]

Home page
 PediatricsHome page
A. O. Jumaan and R. Harpaz
Chickenpox Outbreak in a Highly Vaccinated School Population
Pediatrics, October 1, 2004; 114(4): 1130 - 1130.
[Full Text] [PDF]

Home page
 PediatricsHome page
P. R. Cieslak, K. Hedberg, and L. E. Lee
Chickenpox Outbreak in a Highly Vaccinated School Population: In Reply
Pediatrics, October 1, 2004; 114(4): 1131 - 1131.
[Full Text] [PDF]

Home page
 PediatricsHome page
K. Heath and B. Watson
Chickenpox Outbreak in a Highly Vaccinated School Population
Pediatrics, October 1, 2004; 114(4): 1130 - 1131.
[Full Text] [PDF]

Home page
 JAMAHome page
J. F. Seward, J. X. Zhang, T. J. Maupin, L. Mascola, and A. O. Jumaan
Contagiousness of Varicella in Vaccinated Cases: A Household Contact Study
JAMA, August 11, 2004; 292(6): 704 - 708.
[Abstract] [Full Text] [PDF]

Home page
 AAP Grand RoundsHome page
M. H. Rathore
Varicella Vaccine Effective but Booster May Be Needed
AAP Grand Rounds, May 1, 2004; 11(5): 49 - 50.
[Full Text] [PDF]